- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06426550
Clinical and Microbiological Evaluation of Laser Therapy in the Treatment of Periodontal Disease in Stages III and IV
The aim of this clinical trial is to evaluate photodynamic therapy and photobiomodulation in the periodontitis treatment. To evaluate the clinical and microbiological response of conventional periodontal treatment associated with photodynamic therapy and photobiomodulation with red or infrared laser.
Participants will receive periodontal treatment carried out with the use 0.005% methylene blue and laser therapy (photodynamic therapy), associated with conventional periodontal treatment, as well as the use of photobiomodulation with red or infrared laser associated with conventional periodontal treatment in participants with periodontitis. So, twenty periodontitis patients will be selected and separated in two groups compared with placebo. Clinical and microbiological parameters will be evaluated at baseline and 3 months after periodontal treatment: plaque Index, bleeding on probe, probing depth, gingival recession and clinical attachment level.
Study Overview
Status
Conditions
Detailed Description
Periodontitis is a chronic, inflammatory and multifactorial disease, caused by an interaction between debiotic biofilm and its products and an exacerbated host response, leading to the progressive destruction of the supporting periodontium (bone, cement and periodontal ligament), causing loss of clinical attachment. and radiographic, bleeding on probing and periodontal pocket formation. Periodontal disease has a high prevalence and is one of the main causes of edentulism, with a great negative impact on chewing function, aesthetics and quality of life related to oral health. It is, therefore, considered a serious public health problem.
Conventional periodontal therapy consists of scaling and root planing (SRP) and control of supragingival plaque, but in some cases it has been shown to be ineffective in treating periodontitis, especially in difficult to access areas such as furcations and deep pockets. These cases benefit from adjuvant therapies, such as laser therapy, to help heal periodontal tissues, reduce microorganisms and improve clinical parameters.
Photobiomodulation and photodynamic therapy have been widely applied in the treatment of periodontal disease, due to their clinical, cellular and bactericidal effects. When associated with conventional periodontal therapy, its benefits increase, promoting a significant reduction in probing depth, number of deep pockets and bleeding. Furthermore, significant reduction of periodontopathogens and Candida albicans can be observed in the literature after photobiomodulation and photodynamic therapy.
Despite the benefits found when different laser therapy protocols are used in periodontal treatment, due to the lack of studies with high methodological quality and weak evidence in the existing literature, more studies are needed to prove their effects, establish appropriate protocols and evaluate the antimicrobial potential in periodontopathogens, which remains debatable, as recent systematic reviews point out.
The direct benefits of this study are the treatment of periodontal disease for the participants and for the scientific community to indicate new forms of periodontal therapy using different protocols of laser therapy associated with periodontal instrumentation. All tooth pocket sites in all groups will receive treatment.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rio de Janeiro
-
Nova Friburgo, Rio de Janeiro, Brazil, 28625650
- Fluminense Federal University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult participants with periodontal disease;
- Four or more periodontal sites with PPD≥6 mm and CAL≥5 mm, non-adjacent;
- Generalized periodontitis, with more than 30% of the sites involved (Caton et al., 2018);
- Stages III and IV of periodontal disease (Caton et al., 2018);
Exclusion Criteria:
- Participants with hypersensitivity to the components of the 0.005% methylene blue gel;
- Received periodontal treatment in the last six months;
- Drugs (alcoholics, use of anti-inflammatories and antibiotics in the last 3 months);
Any evidence of systemic modifying factors which may directly interfere with the completion of the work (bias), such as:
- Pregnant and breastfeeding women;
- Hormone replacement therapy;
- Smoking;
- Hyperglycemia;
- Osteoporosis;
- Diagnosed with HIV+ or AIDS.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Saline solution - Control (C)
Saline gel will be applied in the periodontal pocket and, after 5 minutes, the laser application will be simulated, with the device in inactive mode.
|
Conventional periodontal treatment, consisting of scaling and root planing, will be performed using ultrasonic instrumentation complemented by Gracey curettes, followed by application of saline solution as the control treatment.
|
|
Experimental: Antimicrobial photodynamic therapy and 0.005% methylene blue (aPDT)
Photosensitization will be performed with 0.005% methylene blue gel for 5 minutes, and photodynamic therapy will be applied with a red laser (660 nm) using a DuoⓇ laser with the optical fiber inside the periodontal pocket in back and forth movements, for 90s, 9 joules of energy, dose of 508.5J/cm2, irradiance of 5.65W/cm2 and power of 100mW.
|
Conventional periodontal treatment, consisting of scaling and root planing, will be performed using ultrasonic instrumentation complemented by Gracey curettes, followed by antimicrobial photodynamic therapy (aPDT) with 0.005% methylene blue as the photosensitizer.
|
|
Experimental: Photobiomodulation with a red laser (PBM-RL)
Photobiomodulation will be performed with a red laser (660 nm) using a DuoⓇ laser with the optical fiber inside the periodontal pocket in back and forth movements, for 90s, 9 joules of energy, dose of 508.5J/cm2, irradiance of 5.65W/cm2 and power of 100mW.
The application of the gel with an empty syringe will be simulated, and waited 5 minutes.
|
Conventional periodontal treatment, consisting of scaling and root planing, will be performed using ultrasonic instrumentation complemented by Gracey curettes, followed by Photobiomodulation with a red laser (PBM-RL).
|
|
Experimental: Photobiomodulation with an infrared laser (PBM-IRL)
Photobiomodulation will be performed with an infrared laser (808 nm) using a DuoⓇ laser with the optical fiber inside the periodontal pocket in back and forth movements, for 90s, 9 joules of energy, dose of 508.5J/cm2, irradiance of 5.65W/cm2 and power of 100mW.
The application of the gel with an empty syringe will be simulated, and waited 5 minutes.
|
Conventional periodontal treatment, consisting of scaling and root planing, will be performed using ultrasonic instrumentation complemented by Gracey curettes, followed by photobiomodulation with an infrared laser (PBM-IRL).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plaque index (PI)
Time Frame: Baseline and 3 months
|
Plaque index will be expressed in percentage per individual to evaluate the supragingival plaque control.
|
Baseline and 3 months
|
|
Bleeding on probing (BOP)
Time Frame: Baseline and 3 months
|
Bleeding on probing (BOP) will be expressed in percentage per individual to evaluate presence of BOP <20% good results.
|
Baseline and 3 months
|
|
Pocket probing depth (PPD)
Time Frame: Baseline and 3 months
|
Pocket probing depth (PPD) will be evaluated in millimeters.
The measure will be performed at six sites per tooth using a periodontal probe.
The PPD corresponds to the distance from the gingival margin to the apical portion of the gingival sulcus or periodontal pocket.
|
Baseline and 3 months
|
|
Gingival recession (GR)
Time Frame: Baseline and 3 months
|
Gingival recession (GR) will be measured clinically in millimeters with a periodontal probe as the distance from the cemento-enamel junction to the depth of the free gingival margin.
|
Baseline and 3 months
|
|
Clinical attachment level (CAL)
Time Frame: Baseline and 3 months
|
Clinical attachment level (CAL) will be measured clinically in millimeters with a periodontal probe and corresponds as the distance from the cemento-enamel junction to the base of the periodontal pocket.
CAL represents the extension of periodontal support that has been lost around a tooth.
|
Baseline and 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Microbiogical analysis
Time Frame: Baseline and 3 months
|
Pooled biofilms from gingival fluid of four sites with PPD with 6 mm or more will be collected to evaluate the presence of periodontal pathogens.
The samples will be collected from the selected sites and stored in eppendorfs with PBS 1X in -20oC until the microbiological analyses, that will consist in DNA extraction, electroforesis and qualitative polymerase chain reaction (PCR).
|
Baseline and 3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Gabriela AC Camargo, Doctor, Fluminense Federal University
Publications and helpful links
General Publications
- Akram Z, Al-Shareef SA, Daood U, Asiri FY, Shah AH, AlQahtani MA, Vohra F, Javed F. Bactericidal Efficacy of Photodynamic Therapy Against Periodontal Pathogens in Periodontal Disease: A Systematic Review. Photomed Laser Surg. 2016 Apr;34(4):137-49. doi: 10.1089/pho.2015.4076. Epub 2016 Mar 16.
- Akram Z. How effective is adjunctive antimicrobial photodynamic therapy in treating deep periodontal pockets in periodontal disease? A systematic review. J Investig Clin Dent. 2018 Nov;9(4):e12345. doi: 10.1111/jicd.12345. Epub 2018 Jun 4.
- Ren C, McGrath C, Jin L, Zhang C, Yang Y. The effectiveness of low-level laser therapy as an adjunct to non-surgical periodontal treatment: a meta-analysis. J Periodontal Res. 2017 Feb;52(1):8-20. doi: 10.1111/jre.12361. Epub 2016 Mar 2.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mouth Diseases
- Stomatognathic Diseases
- Pathologic Processes
- Chronic Disease
- Disease Attributes
- Pathological Conditions, Signs and Symptoms
- Periodontitis
- Periodontal Diseases
- Periodontal Pocket
- Chronic Periodontitis
- Sulfur Compounds
- Organic Chemicals
- Heterocyclic Compounds
- Heterocyclic Compounds, Fused-Ring
- Pharmaceutical Preparations
- Therapeutics
- Crystalloid Solutions
- Isotonic Solutions
- Solutions
- Laser Therapy
- Phototherapy
- Heterocyclic Compounds, 3-Ring
- Phenothiazines
- Methylene Blue
- Saline Solution
- Low-Level Light Therapy
Other Study ID Numbers
- 78007624.4.0000.5626
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Periodontitis
-
Mahsa UniversityRecruitingPeriodontitis | Periodontitis Chronic Generalized Moderate | Periodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Chronic Generalized Severe | Periodontitis, Chronic | Periodontitis Stage II | Periodontitis Chronic Localized Slight | Periodontitis Stage IIIMalaysia
-
Shanghai Ninth People's Hospital Affiliated to...Not yet recruitingPeriodontitis Stage II | Periodontitis Stage III | Periodontitis Stage IV
-
Misr University for Science and TechnologyCompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage II | Periodontitis Stage IIIEgypt
-
Cairo UniversityRecruitingPeriodontitis | Periodontitis Stage II | Periodontitis Stage IIIEgypt
-
Ataturk UniversityCompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage IITurkey (Türkiye)
-
Al-Azhar UniversityNot yet recruitingStage IV Periodontitis | Advanced Periodontitis | Stage III PeriodontitisEgypt
-
Panineeya Mahavidyalaya Institute of Dental Sciences...Research Institute for Genetic and Human TherapyUnknownGeneralized Adult Periodontitis
-
Duygu DegirmenciogluNot yet recruitingApical PeriodontitisTurkey (Türkiye)
-
University of ZagrebActive, not recruitingApical PeriodontitisCroatia
-
Hilal Çuhadar BeşiroğluCompletedApical PeriodontitisTurkey (Türkiye)
Clinical Trials on Antimicrobial photodynamic therapy and 0.005% methylene blue (PDT)
-
University of Nove de JulhoEnrolling by invitation
-
Roaa Hadi Hussein JasemEnrolling by invitationPhysiological Gingival PigmentationEgypt
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedPeriodontal DiseasesBrazil
-
Chulalongkorn UniversityCompleted
-
Escola Bahiana de Medicina e Saude PublicaCompleted
-
Zohaib AkramCompletedRheumatoid Arthritis | Chronic PeriodontitisSaudi Arabia
-
Dartmouth-Hitchcock Medical CenterDUSA Pharmaceuticals, Inc.CompletedActinic CheilitisUnited States
-
Ondine Biomedical Inc.CompletedNosocomial Infection | Surgical Site Infections | Healthcare Associated InfectionsUnited States
-
Ondine Biomedical Inc.Unknown
-
Northwestern UniversityWithdrawn